Nektar Therapeutics
NKTR
NKTR
239 hedge funds and large institutions have $2.35B invested in Nektar Therapeutics in 2021 Q4 according to their latest regulatory filings, with 42 funds opening new positions, 82 increasing their positions, 76 reducing their positions, and 40 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
0.21% more ownership
Funds ownership: 6.08% → 6.29% (+0.21%)
0% more funds holding
Funds holding: 239 → 239 (0)
22% less capital invested
Capital invested by funds: $3.01B → $2.35B (-$658M)
Holders
239
Holding in Top 10
2
Calls
$33.8M
Puts
$24.5M
Top Buyers
| 1 | +$106M | |
| 2 | +$19M | |
| 3 | +$16.5M | |
| 4 |
WP
Woodline Partners
San Francisco,
California
|
+$13.3M |
| 5 |
State Street
Boston,
Massachusetts
|
+$8.68M |
Top Sellers
| 1 | -$97.9M | |
| 2 | -$18M | |
| 3 | -$9.06M | |
| 4 |
Primecap Management
Pasadena,
California
|
-$7.66M |
| 5 |
OCM
Osterweis Capital Management
San Francisco,
California
|
-$6.59M |